BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18063075)

  • 1. Utilization of total thyroidectomy for papillary thyroid cancer in the United States.
    Bilimoria KY; Bentrem DJ; Linn JG; Freel A; Yeh JJ; Stewart AK; Winchester DP; Ko CY; Talamonti MS; Sturgeon C
    Surgery; 2007 Dec; 142(6):906-13; discussion 913.e1-2. PubMed ID: 18063075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer.
    Haigh PI; Urbach DR; Rotstein LE
    Ann Surg Oncol; 2005 Jan; 12(1):81-9. PubMed ID: 15827782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006.
    Griniatsos J; Tsigris C; Kanakis M; Kaltsas G; Michail O; Dimitriou N; Argyrakopoulou G; Delladetsima I; Kyriakou V; Syriou V; Alexandraki K; Pikoulis E; Giannopoulos A; Kouraklis G; Diamanti-Kandaraki E; Felekouras E
    Anticancer Res; 2009 Dec; 29(12):5163-9. PubMed ID: 20044632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery for papillary thyroid carcinoma: is lobectomy enough?
    Mendelsohn AH; Elashoff DA; Abemayor E; St John MA
    Arch Otolaryngol Head Neck Surg; 2010 Nov; 136(11):1055-61. PubMed ID: 21079156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
    Grigsby PW; Reddy RM; Moley JF; Hall BL
    Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Total thyroidectomy of choice in papillary microcarcinoma].
    Pisello F; Geraci G; Sciumè C; Li Volsi F; Modica G
    G Chir; 2007; 28(1-2):13-9. PubMed ID: 17313727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size.
    McCoy KL; Jabbour N; Ogilvie JB; Ohori NP; Carty SE; Yim JH
    Surgery; 2007 Dec; 142(6):837-44; discussion 844.e1-3. PubMed ID: 18063065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States.
    Haigh PI; Urbach DR; Rotstein LE
    Surgery; 2004 Sep; 136(3):609-16. PubMed ID: 15349109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis.
    Esnaola NF; Cantor SB; Sherman SI; Lee JE; Evans DB
    Surgery; 2001 Dec; 130(6):921-30. PubMed ID: 11742318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer.
    Barney BM; Hitchcock YJ; Sharma P; Shrieve DC; Tward JD
    Head Neck; 2011 May; 33(5):645-9. PubMed ID: 20687168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total thyroidectomy is the recommended treatment for all Papillary Thyroid Carcinoma (PTC).
    Santini J; Haddad A
    Acta Otorhinolaryngol Belg; 1999; 53(3):161-4. PubMed ID: 10635384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of total thyroidectomy for differentiated thyroid cancer in children.
    Raval MV; Bentrem DJ; Stewart AK; Ko CY; Reynolds M
    Ann Surg Oncol; 2010 Oct; 17(10):2545-53. PubMed ID: 20429037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodule heterogeneity as shown by size differences between the targeted nodule and the tumor in thyroidectomy specimen: a cause for a false-negative diagnosis of papillary thyroid carcinoma on fine-needle aspiration.
    Siddiqui MA; Griffith KA; Michael CW; Pu RT
    Cancer; 2008 Feb; 114(1):27-33. PubMed ID: 18085634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer?
    Del Rio P; Cataldo S; Sommaruga L; Concione L; Arcuri MF; Sianesi M
    Minerva Endocrinol; 2008 Mar; 33(1):1-5. PubMed ID: 18277374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
    Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of surgical treatment on outcomes for papillary thyroid cancer.
    Bilimoria KY; Zanocco K; Sturgeon C
    Adv Surg; 2008; 42():1-12. PubMed ID: 18953806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival impact of treatment options for papillary microcarcinoma of the thyroid.
    Lin HW; Bhattacharyya N
    Laryngoscope; 2009 Oct; 119(10):1983-7. PubMed ID: 19655332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
    Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
    Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of surgically managed pediatric thyroid cancer.
    Bargren AE; Meyer-Rochow GY; Delbridge LW; Sidhu SB; Chen H
    J Surg Res; 2009 Sep; 156(1):70-3. PubMed ID: 19577768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.